CLINICAL CHARACTERISTICS AND OUTCOMES OF MYELODYSPLASTIC NEOPLASMS AND ACUTE MYELOID LEUKEMIA WITH MECOM REARRANGEMENT: RESULTS FROM A NATIONWIDE MULTICENTER STUDY.

Introduction: “AML with MECOM rearrangement” was recently categorized by WHO classification 2022 regardless of blast count, which included those present with MDS and AML into this group. We aim to explore frequency, clinical characteristics, and outcomes in this subtype among Thai myeloid neoplasms....

Full description

Bibliographic Details
Main Authors: C. Polprasert, C. Chanswangphuwana, W. Owattanapanich, S. Kungwankiattichai, E. Rattarittamrong, T. Rattanathammethee, A. Tantiworawit, W. Limvorapitak, S. Saengboon, P. Niparuck, T. Puavilai, J. Julamanee, P. Saelue, C. Wanitpongpun, C. Nakhakes, K. Prayongratana, E. Karoopongse, P. Rojnuckarin, C. Sriswasdi
Format: Article
Language:English
Published: Elsevier 2024-01-01
Series:Leukemia Research Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S2213048924000104

Similar Items